Projects funded by the NCN
Selective inhibition of Janus kinases for the treatment of autoimmune hepatitis: Translational PK/PD modelling from molecular to population level
2023/51/D/NZ7/01539
Keywords:
pharmacokinetics pharmacodynamics autoimmune hepatitis PK/PD modeling JAK inhibitors
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ5_7: Human disease treatment
- NZ5_3: Pathogenesis of human diseases
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Collegium Medicum
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 7
Call: SONATA 19 - announced on 2023-09-18
Amount awarded: 1 507 180 PLN
Project start date (Y-m-d): 2024-06-25
Project end date (Y-m-d): 2027-06-24
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.